SCHEMBL4517089

SCHEMBL4517089

CCCCC(CCCC)[Si](C)(Cl)CCCC

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.33
ALDH1A1 P00352 2/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923968 0.77 DNM1 (0.38) DNM1ALDH1A1TDP1
SCHEMBL1569375 0.75 DNM1 (0.36) DNM1ALDH1A1TDP1
SCHEMBL28981796 0.71 DNM1 (0.33) DNM1ALDH1A1TDP1
SCHEMBL28216210 0.70 DNM1 (0.32) DNM1
SCHEMBL27751696 0.70 DNM1 (0.32) DNM1
SCHEMBL3749524 0.68 LMNA (0.41) DNM1ALDH1A1
SCHEMBL708796 0.68 TSHR (0.38) ALDH1A1TDP1
SCHEMBL446925 0.68
SCHEMBL14760415 0.67 ALDH1A1 (0.34) DNM1ALDH1A1TDP1
SCHEMBL6841669 0.67 DNM1 (0.33) DNM1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160009750-A1 PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2016-01-14 US claimed
WO-2012107532-A1 4-AMINOALCOHOLQUINOLINE DERIVATIVES, ENANTIOSELECTIVE SYNTHESIS METHODS AND THE USE THEREOF Université de Picardie Jules Verne (FR) 2012-08-16 WO claimed
EP-2487157-A1 Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use Université de Picardie Jules Verne (FR) 2012-08-15 EP claimed
CN-114787139-A Processes and intermediates for preparing MCL1 inhibitors 吉利德科学公司 2022-07-22 CN disclosed
US-11220482-B2 Aminopyridinemethanol compounds and their use UNIVERSITE AMIENS PICARDIE JULES VERNE (FR) 2022-01-11 US disclosed
CN-111954676-A 2'3' -Cyclic dinucleotides 捷克共和国有机化学与生物化学研究所 2020-11-17 CN disclosed
CN-111954675-A 3'3' -Cyclic dinucleotides 捷克共和国有机化学与生物化学研究所 2020-11-17 CN disclosed
EP-3704093-A1 NOVEL AMINOPYRIDINEMETHANOL COMPOUNDS AND THEIR USE Université Amiens Picardie Jules Verne (FR) 2020-09-09 EP disclosed
US-20200255379-A1 NOVEL AMINOPYRIDINEMETHANOL COMPOUNDS AND THEIR USE UNIV AMIENS PICARDIE JULES VERNE (FR) 2020-08-13 US disclosed
WO-2012107532-A1 4-AMINOALCOHOLQUINOLINE DERIVATIVES, ENANTIOSELECTIVE SYNTHESIS METHODS AND THE USE THEREOF Université de Picardie Jules Verne (FR) 2012-08-16 WO disclosed
EP-2487157-A1 Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use Université de Picardie Jules Verne (FR) 2012-08-15 EP disclosed
US-20090258883-A1 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds LES LABORATOIRES SERVIER (FR) 2009-10-15 US disclosed
EP-0685234-B1 DRUG COMPOSITION CONTAINING NUCLEIC ACID COPOLYMER NIPPON SHINYAKU CO LTD (JP) 2000-05-10 EP disclosed
US-6020317-A Glycerol derivative, device and pharmaceutical composition NIPPON SHINYAKU CO. LTD. (JP) 2000-02-01 US disclosed
EP-0685457-B1 GLYCEROL DERIVATIVE, DEVICE AND PHARMACEUTICAL COMPOSITION NIPPON SHINYAKU CO LTD (JP) 1999-12-15 EP disclosed
US-5705188-A LIPID MIXTURE, ANTITUMOR AGENTS NIPPON SHINYAKU COMPANY, LTD. (JP) 1998-01-06 US disclosed
EP-0685457-A1 GLYCEROL DERIVATIVE, DEVICE AND PHARMACEUTICAL COMPOSITION NIPPON SHINYAKU COMPANY, LIMITED (JP) 1995-12-06 EP disclosed
EP-0685234-A1 DRUG COMPOSITION CONTAINING NUCLEIC ACID COPOLYMER NIPPON SHINYAKU COMPANY, LIMITED (JP) 1995-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11220482-B2 Aminopyridinemethanol compounds and their use QDPR, PNMT, CYP3A43 DNM1 495/4885ALDH1A1 472/4885TDP1 2290/4885
US-20200255379-A1 NOVEL AMINOPYRIDINEMETHANOL COMPOUNDS AND THEIR USE QDPR, PNMT, CYP3A43 DNM1 415/4885ALDH1A1 736/4885TDP1 2683/4885
US-20090258883-A1 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds IDO1, AHR, IDO2 DNM1 3161/4885ALDH1A1 370/4885TDP1 2926/4885
US-20160009750-A1 PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION PNP, NUDT1, TYMP DNM1 2987/4885ALDH1A1 2698/4885TDP1 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.